INS and Alzheimer disease: Another possible explanation for the presence of AD neurodegeneration is that the histopathological, molecular, and biochemical abnormalities associated with decreased glucose utilization during the disease could point to a link between insulin metabolism and the clinical manifestation of AD [44].